Marijuana financier Pelorus lends nearly $17M to Royal Emerald Pharmaceuticals
Marijuana real estate lender Pelorus Equity Group announced debt financing worth nearly $17 million to specialty-drug company Royal Emerald Pharmaceuticals.
Opinion: 4 ways to empower women in the marijuana industry
Numbers, as they say, don’t lie. But they don’t tell a full story, either.
The number of women working in the cannabis industry is on the decline.
Illinois craft cannabis grower bill highlights tension between big companies, minority entrepreneurs
Back in 2019, many marijuana industry experts trumpeted Illinois as setting a new bar for social equity; State lawmakers created a potential blueprint to provide greater opportunities for minority entrepreneurs in Illinois’ new recreational cannabis industry.
But three years later, the social equity program is still struggling to get off the ground, in part because of lawsuits and the COViD-19 pandemic.
Nevada suspends cannabis company’s license over seed-to-sale tracking issues
Nevada regulators voted to suspend the adult-use and medical cannabis cultivation and production licenses of NLVG, doing business as Desert Bloom, for not properly tracking its marijuana.
Maine scuttles plan to update medical cannabis rules
Maine regulators scrapped a proposed change to rules for its medical cannabis program after caregivers and consumers protested.
Washington state to require pesticide testing for adult-use cannabis products
Washington state regulators will finally require pesticide testing of adult-use cannabis products, which nearly all other markets with legal marijuana programs already require.
Cannabis producer Tilray throws rival Hexo lifeline via $211 million debt purchase, alliance
New York-based Tilray Brands said Thursday it plans to acquire up to $211 million (267.5 million Canadian dollars) in outstanding senior secured notes issued by Hexo Corp., effectively throwing its troubled rival a lifeline and striking an alliance with the Quebec cannabis producer.
